Advertisement

Advertisement

HK:6855 Stock Latest News

Ascentage Pharma Trustee Buys Additional Shares for 2022 RSU Scheme

Company AnnouncementsAscentage Pharma Trustee Buys Additional Shares for 2022 RSU Scheme

Ascentage Pharma Wins Breakthrough Therapy Status in China for First-Line CLL/SLL Drug Combo

PremiumCompany Announcements

Ascentage Pharma Wins Breakthrough Therapy Status in China for First-Line CLL/SLL Drug Combo

4d ago

Ascentage Pharma initiated with an Outperform at William Blair

PremiumThe Fly

Ascentage Pharma initiated with an Outperform at William Blair

9d ago

Ascentage Pharma Trustee Buys HK$5.8 Million in Shares for RSU Scheme

PremiumCompany Announcements

Ascentage Pharma Trustee Buys HK$5.8 Million in Shares for RSU Scheme

9d ago

Ascentage Pharma initiated with a Buy at Citi

PremiumThe Fly

Ascentage Pharma initiated with a Buy at Citi

10d ago

Ascentage Pharma initiated with an Outperform at Citizens

PremiumThe FlyAscentage Pharma initiated with an Outperform at Citizens

12d ago

Ascentage Pharma price target lowered to $33 from $46 at JPMorgan

The Fly

Ascentage Pharma price target lowered to $33 from $46 at JPMorgan

16d ago

Ascentage Pharma Chairman Lifts Stake in Confidence-Building Share Purchase

Company Announcements

Ascentage Pharma Chairman Lifts Stake in Confidence-Building Share Purchase

26d ago

Ascentage Pharma Trustee Buys Shares to Fund 2022 RSU Scheme

PremiumCompany Announcements

Ascentage Pharma Trustee Buys Shares to Fund 2022 RSU Scheme

26d ago

Ascentage Pharma Trustee Buys Shares to Support 2022 RSU Incentive Scheme

PremiumCompany Announcements

Ascentage Pharma Trustee Buys Shares to Support 2022 RSU Incentive Scheme

1M ago

Jeet Mukherjee Initiates Buy on Ascentage Pharma, Citing 2027 NRDL Lisaftoclax Catalyst, Late‑Stage Pipeline Readouts, and Cash Runway Through 2027

PremiumRatings

Jeet Mukherjee Initiates Buy on Ascentage Pharma, Citing 2027 NRDL Lisaftoclax Catalyst, Late‑Stage Pipeline Readouts, and Cash Runway Through 2027

2M ago

Ascentage Pharma Lifts Revenue, Deepens Losses as U.S. Push and BTK Degrader Trials Advance

PremiumCompany Announcements

Ascentage Pharma Lifts Revenue, Deepens Losses as U.S. Push and BTK Degrader Trials Advance

2M ago

Ascentage Pharma Sets Board Meeting to Approve 2026 Interim Results

PremiumCompany AnnouncementsAscentage Pharma Sets Board Meeting to Approve 2026 Interim Results

3M ago

Ascentage Pharma appoints Miyara as CBO, Ziegler as CCO

The Fly

Ascentage Pharma appoints Miyara as CBO, Ziegler as CCO

3M ago

Ascentage Pharma Strengthens Global Commercial Push With Senior Executive Hires

Company Announcements

Ascentage Pharma Strengthens Global Commercial Push With Senior Executive Hires

3M ago

Ascentage Pharma Advances Phase III Oral Combo in CLL: What Investors Should Watch

PremiumCompany Announcements

Ascentage Pharma Advances Phase III Oral Combo in CLL: What Investors Should Watch

3M ago

Ascentage Pharma files to sell American Depositary Shares, no amount given

PremiumThe Fly

Ascentage Pharma files to sell American Depositary Shares, no amount given

3M ago

Ascentage Pharma Sets Up $200 Million Nasdaq ATM Offering Program

PremiumCompany Announcements

Ascentage Pharma Sets Up $200 Million Nasdaq ATM Offering Program

3M ago

Ascentage Pharma management to meet with B. Riley

PremiumThe Fly

Ascentage Pharma management to meet with B. Riley

3M ago

Ascentage Pharma Corrects AGM Date for Share Incentive Scheme Mandate

PremiumCompany AnnouncementsAscentage Pharma Corrects AGM Date for Share Incentive Scheme Mandate

3M ago

Ascentage Pharma Grants New RSUs to 453 Employees Under 2021 Scheme

Company Announcements

Ascentage Pharma Grants New RSUs to 453 Employees Under 2021 Scheme

4M ago

Ascentage Pharma assumed with an Outperform at Oppenheimer

The Fly

Ascentage Pharma assumed with an Outperform at Oppenheimer

4M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >